Serum Bcl-2, caspase-9 and soluble FasL levels as perinatal markers in late preterm pregnancies with intrauterine growth restriction
Intrauterine growth restriction (IUGR) is the inability of the fetus to growand develop in the expected pattern. It occurs in about 5% of pregnancies andis associated with severe fetal mortality and morbidity. Affected infants arealso highly vulnerable to diseases such as perinatal asphyxia, cerebral palsy,meconium aspiration syndrome, coagulation disorders, and immune systemdisorders that require long-term treatment. Apoptosis is thought to play a keyrole in the etiopathogenesis of IUGR. In conclusion, fetal complications arethought to be related to the severity of apoptosis in pregnancies complicatedwith IUGR.The aim of the study was to test the measurability of the severity of apoptosisusing Bcl-2, caspase-9, soluble Fas ligand (sFasL) markers and the maternalblood sample in addition to the diagnostic methods commonly used todiagnose IUGR; and to decrease the rates of adverse perinatal outcomes dueto IUGR and to evaluate the fetal well-being status without feeling a needfor invasive procedures. One hundred and fifty-nine late preterm pregnancieswere included in the study. Eighty were diagnosed with IUGR and the otherswere the control group. During delivery, maternal and umbilical cord bloodsamples were taken. Bcl-2, caspase-9, sFasL marker levels in maternal andumbilical cord sera were determined using ELISA method. Bcl-2 levels werefound to be significantly high in the maternal and umbilical cord sera in theIUGR group. There was also no significant difference between umbilical cordsera of the two groups in terms of sFasL and caspase-9 levels.The results suggest that maternal serum Bcl-2 levels may also be helpfulin the diagnosis of IUGR when used besides the ultrasonographic findings.Multicenter studies with large patient groups will increase knowledge in thisarea.
___
1. Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108.2. Robinson R. The fetal origins of adult disease. BMJ 2001; 322: 375-376.
3. Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011; 37: 501-514.
4. Kadyrov M, Kingdom JCP, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/ intrauterine growth restriction. Am J Obstet Gynecol 2006; 194: 557-563.
5. Khashu M, Narayanan M, Bhargava S, Osiovich H. Perinatal outcomes associated with preterm birth at 33 to 36 weeks' gestation: A population-based cohort study. Pediatrics 2009; 123: 109-113.
6. Martin JA, Hamilton BE, Sutton PD, et al; Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Births: final data for 2005. Natl Vital Stat Rep 2007; 56: 1-103.
7. Dawes GS, Moulden M, Redman CW. Short-term fetal heart rate variation, decelerations, and umbilical flow velocity waveforms before labor. Obstet Gynecol 1992; 80: 673-678.
8. Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol 1999; 181: 1473- 1478.
9. Alfirevic Z, Neilson JP. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2010; 1: CD000073.
10. Westergaard HB, Langhoff-Roos J, Lingman G, Marsal K, Kreiner S. A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics. Ultrasound Obstet Gynecol 2001; 17: 466- 476.
11. Boers KE, Bijlenga D, Mol BW, et al. Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy Childbirth 2007; 7: 12.
12. Fenton TR, Kim JH. A systematic review and metaanalysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59.
13. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7.
14. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012; 2: 72-83.
15. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997; 48(Suppl 1): 11-16.
16. Athapathu H, Jayawardana MA, Senanayaka L. A study of the incidence of apoptosis in the human placental cells in the last weeks of pregnancy. J Obstet Gynaecol 2003; 23: 515-517.
17. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (nearterm) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118: 1207-1214.
18. Korkmaz A, Aydın Ş, Duyan Çamurdan A ve ark. Türkiye’de bebek ölüm nedenlerinin ve ulusal kayıt sisteminin değerlendirilmesi. Çocuk Sağlığı ve Hastalıkları Dergisi 2013; 56: 105-121.
19. Sarıcı D, Sarıcı SÜ. Geç preterm bebeklerde sorunlar. Turkiye Klinikleri J Pediatr Sci 2015; 11: 80-85.
20. Karakus S, Bozoklu Akkar O, Yildiz C, Sancakdar E, Cetin M, Cetin A. Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls. Arch Gynecol Obstet 2016; 293: 351-359.
21. Heazell AEP, Crocker IP. Live and let die–regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 2008; 29: 772-783.
22. Murakoshi H, Matsuo H, Laoag-Fernandez JB, Samoto T, Maruo T. Expression of Fas/ Fas-ligand, Bcl-2 protein and apoptosis in extravillous trophoblast along invasion to the decidua in human term placenta. Endocr J 2003; 50: 199-207.
23. Maruo T, Ishihara N, Samoto T, Murakoshi H, LaoagFernandez JB, Matsuo H. Regulation of human trophoblast proliferation and apoptosis during pregnancy. Early Pregnancy 2001; 5: 28-29.
24. Ishihara N, Matsuo H, Murakoshi H, LaoagFernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186: 158-166.
25. Stepan H, Leo C, Purz S, Höckel M, Horn LC. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 2005; 122: 172-176.
26. Cali U, Cavkaytar S, Sirvan L, Danisman N. Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and Bcl2. Clin Exp Obstet Gynecol 2013; 40: 45-48
27. Aban M, Cinel L, Arslan M, et al. Expression of nuclear factor-kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study. Tohoku J Exp Med 2004; 204: 195-202.
28. Stepan H, Leo C, Purz S, Höckel M, Horn LC. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 2005; 122: 172-176.
29. Shaker OG, Sadik NA. Pathogenesis of preeclampsia: Implications of apoptotic markers and oxidative stress. Hum Exp Toxicol 2013; 32: 1170-1178.
30. Hu WS, Wang ZP, Dong MY, Wang HZ. Expression of Fas and FasL in serum and plasenta of preeclamptic pregnancy and its significance. Zhejiang Da Xue Xue Bao Yi Xue Ban 2005; 34: 499-502.
31. Haeri S, Khoury J, Kovilam O, Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 2008; 199: 278. e1-5.
32. Aktulay A, Üstün Engin Y, Eyi Yapar EG, Yörük Ö, Hançerlioğulları N, Mollamahmutoğulları L. Nonreaktif NST ön tanısının düşük riskli gebeliklerde değerlendirilmesi. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2013; 10: 1542-1544.
33. Eslamian ZL, Zarean E, Moshfeghi M, Heidari Z. Evaluation of the predictive value of fetal Doppler ultrasound for neonatal outcome from the 36th week of pregnancy. J Res Med Sci 2018; 23: 13.
34. Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol 1999; 181: 1473- 1478.
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Nurdan TAÇYILDIZ, Hikmet Gülşah TANYILDIZ, Emel ÜNAL, Handan DİNÇASLAN, Fikret ASARCIKLI, Başak Adaklı AKSOY, Göksel VATANSEVER, Gülsan YAVUZ
Heart rate variability in juvenile systemic lupus erythematosus patients
Özge BAŞARAN, İbrahim İlker ÇETİN, Fatma AYDIN, Nermin UNCU, Nilgün ÇAKAR, Filiz EKİCİ, Banu Çelikel ACAR
Response to “Speech problems and speech delay: possible underdiagnosis of selective mutism”
Pınar Zengin Akkuş, Elif Nursel Özmert, Gökçe Kurtipek, Tuba Çelen Yoldaş
Neslihan KARAKURT, İlker USLU, Canan AYGÜN, Canan ALBAYRAK
Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic
Betül Sözeri, Funda Baştuğ, Hülya Nalçacıoğlu, Hakan Poyrazoğlu, Ayşenur Paç Kısaarslan, Ruhan Düşünsel, Zübeyde Gündüz, Sibel Yel, Nihal Şahin, Sümeyra Özdemir Çiçek
Taliha Öner, Barış Güven, Timur Meşe, Vedide Tavlı, Mehmet Küçük, Nuri Bayram, Rahmi Özdemir, İlker Devrim, Murat Muhtar Yılmazer
An infant with intradural extramedullary synovial sarcoma: the youngest case in the literature
Elif İnanç Gürer, Kamil Karaali, Gülen Tüysüz, Alphan Küpesiz, Koray Yalçın, Elif Güler, Saim Kazan
Ewing sarcoma in an infant and review of the literature
Ferah Yıldız, Diclehan Orhan, Kader Karlı Oğuz, Mustafa Cengiz, Canan Akyüz, Murat Gürkaynak, Melis Gültekin, Çağlayan Selenge Bedük Esen, G. Burça Aydın
Ayşe KAMAN, Gönül TANIR, Emin ÇAKMAKÇI, Pervin DEMİR, Fatma Nur ÖZ, Türkan Aydın TEKE, Özge METİN, Zeynep Gökçe Gayretli AYDIN, Ayşe KARAMAN
Forouzan Rezapur SHAHKOLAİ, Khadijeh BANDEHELAHİ, Akram Karimi SHAHANJARİNİ, Maryam FARHADİAN